From infectious disease to personalized cancer vaccines: Regulatory T cell epitopes determine patient outcomes and suppress neoantigen responses by Annie De Groot | Nov 6, 2018 | 0 comments EpiVax_Oncology_Ancer_SITC_05Nov18_39Wx35H Submit a CommentYou must be logged in to post a comment.